EFFECTIVE TUMOR VACCINE GENERATED BY FUSION OF HEPATOMA-CELLS WITH ACTIVATED B-CELLS

被引:143
作者
GUO, YJ [1 ]
WU, MC [1 ]
CHEN, H [1 ]
WANG, XN [1 ]
LIU, GL [1 ]
LI, GL [1 ]
MA, J [1 ]
SY, MS [1 ]
机构
[1] CASE WESTERN RESERVE UNIV,INST PATHOL,CLEVELAND,OH 44106
关键词
D O I
10.1126/science.7507262
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
Fusion of BERH-2 rat hepatocellular carcinoma cells with activated B cells produced hybrid cells that lost their tumorigenicity and became immunogenic. Syngeneic rats injected with BERH-2-B hybrid cells became resistant to challenge with parental BERH-2 cells, and rats with established BERH-2 hepatomas were cured by subsequent injection of BERH-2-B cells. Both CD4+ and CD8+ cells were essential for the induction of protective immunity; however, only CD8+ cells were required for the eradication of BERH-2 tumors. The generation of hybrid tumor cells that elicit antitumor immune responses may be a useful strategy for cancer immunotherapy.
引用
收藏
页码:518 / 520
页数:3
相关论文
共 18 条
  • [1] ALAN J, 1988, IMMUNOCHEMISTRY PRAC, pCH2
  • [2] TUMOR SUPPRESSION AFTER TUMOR-CELL TARGETED TUMOR-NECROSIS-FACTOR-ALPHA GENE-TRANSFER
    BLANKENSTEIN, T
    QIN, ZH
    UBERLA, K
    MULLER, W
    ROSEN, H
    VOLK, HD
    DIAMANTSTEIN, T
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 1991, 173 (05) : 1047 - 1052
  • [3] COSTIMULATION OF ANTITUMOR IMMUNITY BY THE B7 COUNTERRECEPTOR FOR THE LYMPHOCYTE-T MOLECULES CD28 AND CTLA-4
    CHEN, LP
    ASHE, S
    BRADY, WA
    HELLSTROM, I
    HELLSTROM, KE
    LEDBETTER, JA
    MCGOWAN, P
    LINSLEY, PS
    [J]. CELL, 1992, 71 (07) : 1093 - 1102
  • [4] CHESTNUT RW, 1981, J IMMUNOL, V128, P1075
  • [5] ELIOT BE, 1989, ADV CANCER RES, V53, P181
  • [6] INTERLEUKIN-2 PRODUCTION BY TUMOR-CELLS BYPASSES T-HELPER FUNCTION IN THE GENERATION OF AN ANTITUMOR RESPONSE
    FEARON, ER
    PARDOLL, DM
    ITAYA, T
    GOLUMBEK, P
    LEVITSKY, HI
    SIMONS, JW
    KARASUYAMA, H
    VOGELSTEIN, B
    FROST, P
    [J]. CELL, 1990, 60 (03) : 397 - 403
  • [7] GEORGE JT, 1993, CANCER RES, V53, P2374
  • [8] Guo Y., UNPUB
  • [9] GUO YJ, 1988, J MIL MED COLL PEOPL, V3, P272